IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sangamo Therapeutics Inc (SGMO)

CUSIP: 800677106 | NYSE | Healthcare · Biotechnology | Micro Cap | 816 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AArmistice Capital, LLC38,860,8199.4%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/AArmistice Capital, LLC38,860,819
9.4% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched

Institutional Holders — Q2 2026

Nomura Asset Management International Inc.400,000
0.0% of portfolio›$22.0K
Simplex Trading, LLC76,500
0.0% of portfolio›$4.1K
Axiom Investment Management LLC25,375
0.0% of portfolio›$1.4K
Flow Traders U.S. LLC21,532
0.0% of portfolio›$1
Heritage Investment Group, Inc.10,000
0.0% of portfolio›$539
Barclays PLC1
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Nomura Asset Management International Inc.
400,000$22.0K0.0%GARPMediumPhiladelphia, PA2026-08-14
Simplex Trading, LLC
76,500$4.1K0.0%CoreVery HighChicago, IL2026-08-12
Axiom Investment Management LLC
25,375$1.4K0.0%CoreN/ANew York, NY2026-07-31
Flow Traders U.S. LLC
21,532$10.0%ETFVery HighNew York, NY2026-08-14
Heritage Investment Group, Inc.
10,000$5390.0%ETFVery LowPompano Beach, FL2026-07-29
Barclays PLC
1$00.0%CoreMediumLondon, United Kingdom2026-08-14